Exploring Therapies for Melanoma: What's New?
Published: Feb 12, 2024
Melanoma treatment has evolved with new therapies offering hope for better outcomes. Discover the latest advancements.
Contents
Adjuvant and Neoadjuvant Therapies
Adjuvant therapy is given after surgery to eliminate any remaining cancer cells. Neoadjuvant therapy, on the other hand, is administered before surgery to shrink tumors. Both approaches aim to improve survival rates and reduce recurrence.
Immunotherapy: A Game Changer
Immunotherapy harnesses the body's immune system to fight cancer. Drugs like checkpoint inhibitors have shown promising results in treating advanced melanoma. These treatments can potentially lead to long-term remission in some patients.
Targeted Therapy
Targeted therapy involves drugs that attack specific genetic changes in melanoma cells. This approach can effectively halt cancer growth and spread. Personalized treatment plans based on genetic testing are becoming more common.
Frequently Asked Questions
It's treatment given after surgery to target remaining cancer cells.
It boosts the immune system to combat cancer cells.
It focuses on specific genetic mutations in cancer cells.
Yes, they have improved survival rates in melanoma patients.
Key Takeaways
Emerging therapies offer new hope for melanoma patients, changing the treatment landscape.
Get started by exploring these treatment options with Doctronic to find the best plan for you.Related Articles
References
Cascinelli N. Margin of resection in the management of primary melanoma. Semin Surg Oncol 1998; 14:272.
Always discuss health information with your healthcare provider.